A review on pelvic inflammatory disease

International Journal of STD and AIDS

Volumn 16, Issue 11, 2005, Pages 715-721

  Barrett, S ^a   Taylor, C ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Aetiology; Management; PID; Risks

Indexed keywords

ANTIBIOTIC AGENT; CEFOXITIN; DOXYCYCLINE; ORAL CONTRACEPTIVE AGENT; PROBENECID;

ANAEROBIC BACTERIUM; BACTERIAL INFECTION; BARRIER CONTRACEPTION; CHLAMYDIA; CHLAMYDIASIS; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DISEASE SEVERITY; DOPPLER FLOWMETRY; GONORRHEA; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HEALTH EDUCATION; HISTOPATHOLOGY; HOSPITAL PATIENT; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; LAPAROSCOPY; META ANALYSIS; MICROBIOLOGICAL EXAMINATION; MYCOPLASMA GENITALIUM; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL CONTRACEPTION; OUTPATIENT; PATHOGENESIS; PELVIC INFLAMMATORY DISEASE; PILL; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RISK FACTOR; SCREENING; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VAGINAL LAVAGE;

FEMALE; HUMANS; INTRAUTERINE DEVICES; PELVIC INFLAMMATORY DISEASE; RISK FACTORS;

EID: 27844602914     PISSN: 09564624     EISSN: 09564624     Source Type: Journal    
DOI: 10.1258/095646205774763270     Document Type: Review

References (40)

1. Simms I, Stephenson JM. Pelvic inflammatory disease epidemiology: what do we know and what do we need to know. Sex Transm Infect 2000;76:80-7
2. Westrom L. Sexually transmitted diseases and infertility. Sex Transm Infect 1994;21:S32-7
3. Bevan CD, Johal BJ, Mumtaz G, et al. Clinical, laparoscopic and microbiological findings in acute salpingitis: report on a UK cohort. Br J Obstet Gynaecol 1995;102:407-14
4. Yudin MH, Hillier SL, Wiesenfeld HC. Vaginal polymorphonuclear leukocytes and bacterial vaginosis as markers for histologic endometritis among women without symptoms of pelvic inflammatory disease. Am J Obstet Gynecol 2003;188:318-23
5. Wiesenfeld HC, Hillier SL, Krohn MA, et al. Lower genital tract infection and endometritis: insight on subclinical pelvic inflammatory disease. Obstet Gynecol 2002;100: 456-63
6. Paavonen J, Teisala K, Heinonen PK, et al. Microbiological and histological findings in acute pelvic inflammatory disease. Br J Obstet Gynaecol 1878;94:454-60
7. Korn AP, Bolan G, Padian N, et al. Plasma cell endometritis in women with symptomatic bacterial vaginosis. Obstet Gynaecol 1995;85:387-90
8. Hillier SL, Kiviat NB, Hawes SE, et al. Role of BV-associated micro-organisms in endometritis. Am J Obstet Gynecol 1996;175:435-41
9. Ness RB, Hillier SL, Kip KE, et al. Does BV increase the risk of gonococcal/chlamydial cervicitis and pelvic inflammatory disease. BASHH/ASTDA Spring Meeting, Bath, 2004, abstract no. O10
10. Moller BR, Taylor-Robinson D, Furr PM, Freundt EA. Acute upper genital-tract disease in female monkeys provoked experimentally by Mycoplasma genitalium. Br J Exp Pathol 1985;66:417-26
11. Simms I, Eastick K, Mallinson H, et al. Associations between Mycoplasma genitalium, Chlamydia trachomatis and pelvic inflammatory disease. J Clin Pathol 2003;56:616-18
12. Cohen CR, Manhart LE, Bukusi EA, et al. Association between Mycoplasma genitalium and acute endometritis. Lancet 2002;359:765-6
13. Mann SN, Smith JR, Barton SE. The diagnosis and management of pelvic inflammatory disease. In: Barton SE, Hay P, eds. Handbook of Genitourinary Medicine. London: Edward Arnold, 1999;160-9
14. Washington A, Aral S, Wolner-Hanssen P, et al. Assessing risk for pelvic inflammatory disease and its sequelae. JAMA 1991;266:2581-6
15. Gareen IF, Greenland S, Morgenstern H. Intrauterine devices and pelvic inflammatory disease: meta-analyses of published studies, 1974-1990. Epidemiology 2000;11:589-97
16. Wolner-Hanssen P, Eschenbach DA, Paavonen J, et al. Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use. JAMA 1990;263:54-9
17. Kimani J, Maclean JW, Bwayo JJ, et al. Risk factors for chlamydial trachomatis. Pelvic inflammatory disease among sex workers in Nairobi, Kenya. J Infect Dis 1996;173:1437-44
18. Cottingham J, Hunter D. Chlamydial trachomatis and oral contraceptive use: a quantitative review. Genitourin Med 1992;68:209-16
19. Aral SO, Mosher WD, Cates W. Contraceptive use, pelvic inflammatory disease and fertility problems among American women: 1982. Am J Obstet Gynecol 1987;157:59-64
20. Ness RB, Soper DE, Holley RL, et al. Hormonal and barrier contraception and risk of upper genital tract disease in the pelvic inflammatory disease evaluation and clinical health study. Am J Obstet Gynecol 2001;185:121-7
21. Ellish NJ, Weisman CS, Celentano D, et al. Reliability of partner reports of sexual history in a heterosexual population at a sexually transmitted disease clinic. Sex Transm Dis 1996;23:446-52
22. Wolner-Hanssen P, Eschenbach DA, Paavonen J, et al. Association between vaginal douching and acute pelvic inflammatory disease. JAMA 1990;263:1936-41
23. Ness RB, Soper DE, Holley RL, et al. Douching and endometritis. Results from the pelvic inflammatory disease evaluation and clinical health study. Sex Transm Dis 2001;28:240-5
24. Rothman KJ, Punch DP, Alfredson T, et al. Randomised field trial of vaginal douching, pelvic inflammatory disease, and pregnancy. Epidemiology 2003;14:340-8
25. Ross JD. What is endometritis and does it need treatment? Sex Transm Infect 2004;80:252-3
26. Ness RB, Brunham RC, Shen C, et al. Associations among human leukocyte antigen (HLA) class II DQ variants, bacterial STIs, endometritis and fertility among women with clinical pelvic inflammatory disease. Sex Transm Dis 2004;31:301-4
27. Westrom L, Mardh PA. Acute Pelvic Inflammatory Disease - Sexually Transmitted Diseases. 2nd edn. New York: Mcgraw-Hill, 1990;593-13
28. Pieper JF, Ness RB, Blume J, et al. Clinical predictors of endometritis women with symptoms and signs of pelvic inflammatory disease. Am J Obstet Gynecol 2001;184:856-63
29. Simms I, Warbuton F, Westrom L. Diagnosis of pelvic inflammatory disease: time for a rethink. Sex Transm Infect 2003;79:491-4
30. Sellors J, Mahoney J, Goldsmith C, et al. The accuracy of clinical findings and laparoscopy in pelvic inflammatory disease. Am J Obstet Gynecol 1991;164:13-20
31. Kiviat NB, Wolner-Hanssen P, Eschenbach DA, et al. Endometrial histopathology in patients with culture-proved upper genital tract infection and laparoscopically diagnosed acute salpingitis. Am J Surg Pathol 1990;14:167-75
32. Ross JD. An update on pelvic inflammatory disease. Sex Transm Infect 2002;78:18-19
33. Clinical Effectiveness Group for BASHH. Guidelines for the Management of Pelvic Infection and Perihepatitis 2001 [www.bashh.org/guidelines/2002/pid_0601. pdf]
34. Royal College Of Obstetricians And Gynaecologist. Management of Acute Pelvic Inflammatory Disease. Guideline No. 32. London: RCOG, 2003 [www.rcog.org.uk/guidelines.asp? PageID=106&GuidelineID=49]
35. Westrom L, Joesoef R, Reynolds G, et al. Pelvic inflammatory disease and fertility: a cohort study of 1844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis 1992;19:185-92
36. Ness RB, Soper DE, Holley RL, et al. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the pelvic inflammatory disease evaluation and clinical health study. Am J Obstet Gynecol 2002;186:929-37
37. Hillis S, Joesoef R, Marchbanks P, et al. Delayed care of pelvic inflammatory disease as a risk factor for impaired infertility. Am J Obstet Gynecol 1993;86:321-5
38. Egger M, Low N, Davey Smith G, et al. Screening for chlamydial infections and the risk of ectopic: ecological study. BMJ 1998;316:1776-80
39. Scholes D, Stergachis A, Heidrich FE, et al. Prevention of pelvic inflammatory disease by screening for cervical chlamydia infection. N Engl J Med 1996;334:1362-6
40. Anon. HPA website at: [www.hpa.org.uk/infections/topics_az/hiv_and_sti/ epidemiology/sti_slides_2003.zip]